Jessica N Nichol
Overview
Explore the profile of Jessica N Nichol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo Q, Li V, Nichol J, Huang F, Yang W, Preston S, et al.
Cancer Res
. 2024 Apr;
84(8):1373.
PMID: 38616659
No abstract available.
2.
Yang W, Khoury E, Guo Q, Prabhu S, Emond A, Huang F, et al.
Oncogene
. 2020 Mar;
39(18):3650-3665.
PMID: 32132651
The BRAF mutation occurs in more than 50% of cutaneous melanomas, and results in the constitutive activation of the mitogen-activated protein kinases (MAPK) pathway. MAP kinase-interacting serine/threonine-protein kinase 1 and...
3.
Guo Q, Li V, Nichol J, Huang F, Yang W, Preston S, et al.
Cancer Res
. 2019 Jan;
79(7):1646-1657.
PMID: 30659022
The mechanisms by which breast cancers progress from relatively indolent ductal carcinoma (DCIS) to invasive ductal carcinoma (IDC) are not well understood. However, this process is critical to the acquisition...
4.
Dahabieh M, Ha Z, Di Pietro E, Nichol J, Bolt A, Goncalves C, et al.
Cell Death Differ
. 2017 Jul;
24(11):1912-1924.
PMID: 28731463
Peroxisomes are a critical rheostat of reactive oxygen species (ROS), yet their role in drug sensitivity and resistance remains unexplored. Gene expression analysis of clinical lymphoma samples suggests that peroxisomes...
5.
Dupere-Richer D, Kinal M, Pettersson F, Emond A, Calvo-Vidal M, Nichol J, et al.
Leuk Lymphoma
. 2016 May;
58(1):218-221.
PMID: 27185211
No abstract available.
6.
Nichol J, Galbraith M, Kleinman C, Espinosa J, Miller Jr W
Cell Rep
. 2016 Mar;
14(12):2938-49.
PMID: 26997274
Perturbation in the transcriptional control of genes driving differentiation is an established paradigm whereby oncogenic fusion proteins promote leukemia. From a retinoic acid (RA)-sensitive acute promyelocytic leukemia (APL) cell line,...
7.
Nichol J, Garnier N, Miller Jr W
Best Pract Res Clin Haematol
. 2014 Jun;
27(1):19-31.
PMID: 24907014
If looking for a mnemonic to remember the relevant facts about acute promyelocytic leukemia (APL), one just has to remember that APL is a disease of A's. It is acute...
8.
Garnier N, Redstone G, Dahabieh M, Nichol J, del Rincon S, Gu Y, et al.
Mol Pharmacol
. 2014 Jan;
85(4):576-85.
PMID: 24431147
Darinaparsin (Dar; ZIO-101; S-dimethylarsino-glutathione) is a promising novel organic arsenical currently undergoing clinical studies in various malignancies. Dar consists of dimethylarsenic conjugated to glutathione (GSH). Dar induces more intracellular arsenic...
9.
Nichol J, Petruccelli L, Miller Jr W
Front Biosci (Landmark Ed)
. 2009 Mar;
14(6):2293-306.
PMID: 19273202
Post-translational modifications, such as acetylation and ubiquitination, can greatly expand the functionality of a particular protein. The promyelocytic leukemia (PML) protein is a functionally promiscuous protein with proposed roles in...
10.
Rousseau C, Nichol J, Pettersson F, Couture M, Miller Jr W
Mol Cancer Res
. 2004 Sep;
2(9):523-31.
PMID: 15383631
The ability of retinoids to inhibit breast cancer cell growth correlates with estrogen receptor (ER) alpha status, as shown by the antiproliferative effects of retinoids in ERalpha-positive breast cancer cells...